ALGN – Align Technology, Inc.

Align Technology, Inc. (ALGN) Monthly Stock Report – November 13, 2025

Company Overview

Align Technology, Inc., headquartered in Tempe, Arizona, operates within the Medical Instruments & Supplies industry, a vital segment of the healthcare sector. The company specializes in providing innovative orthodontic solutions, prominently featuring Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners. Align’s products cater to the diverse needs of dental professionals and their patients, ranging from adults to younger patients, through comprehensive treatment packages. Since its establishment in 1997, Align Technology has expanded its product range to include advanced imaging systems and CAD/CAM services, demonstrating a commitment to equipping dental professionals with high-quality tools for enhanced care and treatment outcomes.

The healthcare sector, particularly the medical instruments and supplies industry, has garnered increasing attention due to its growth potential. Align’s innovative approach positions it strategically to capitalize on the rising demand for advanced dental solutions. This has led to a buy recommendation being issued by analysts, reflecting strong confidence in the company’s future prospects.

52-Week Price Performance Analysis

Align Technology’s stock has undergone a considerable transformation over the past year. As of the latest trading session, the stock price stands at $141.69, reflecting a decline of approximately 36.07% from its 52-week high of $240, reached in November 2024. The stock also remains substantially above its 52-week low of $122, indicating some resilience.

Analyzing the stock’s 52-week price chart reveals a predominantly bearish trend characterized by a series of lower highs and lower lows, indicating a persistent downward momentum. The stock has been struggling to breach a crucial resistance level at $220, while the recent support level has been established at around $140.

• Key Support Level: $140
• Key Resistance Level: $220
• Current Price: $141.69
• Fifty-Day Moving Average: $132.67

The moving average has often acted as a resistance point, with the stock failing to establish a robust bullish momentum when it approaches that line. The stabilization of the stock price near $141.69 suggests a potential base formation; however, for a bullish reversal to materialize, it must convincingly break through both the downward trend line and the moving average. Investors must remain alert for volume surges that could signal a shift in momentum, as a sustained move above these critical levels may present a re-entry opportunity. Conversely, the bearish sentiment evident in charting suggests cautious monitoring around these key price levels.

Financial Performance and Metrics

Align Technology reported total revenue of approximately $3.98 billion, demonstrating both financial stability and a solid market presence. The company also recorded an EBITDA of $810.89 million, showcasing its strong ability to generate profit and effectively manage operating costs.

Here are some key financial metrics:

• Total Revenue: $3.98 billion
• EBITDA: $810.89 million
• Shares Outstanding: 71,749,995
• Current Stock Price: $141.69
• Price Target (High): $220.00
• Price Target (Mean): $180.50
• Short Interest: 2,580,620 shares (4.67% of float)

Notably, the company’s financial health indicators, including its robust EBITDA margin, position it favorably for long-term growth opportunities in a competitive landscape. The substantial revenue figure not only reflects the operational effectiveness of Align Technology but also signals the potential for expansion within its industry in light of growing healthcare demands.

Recent News and Developments

Align Technology has actively engaged in initiatives reflecting its robust market position and forward-looking strategies. Recently, the company announced a $225 million open market stock repurchase, completing its previously authorized $1 billion repurchase program initiated in January 2023. This move underscores the company’s strong balance sheet and confidence in its growth trajectory.

In the third quarter of 2025, Align reported revenues of $995.7 million, marking a 1.8% year-over-year increase and surpassing analyst expectations. Following the earnings release, the stock experienced a 15.5% price increase, indicating strong positive market sentiment.

Additionally, the launch of the Align X-ray Insights solution, an AI-powered software designed for enhancing dental diagnostics, further solidifies Align’s commitment to digital innovation in dentistry and positions it competitively in the evolving healthcare landscape.

Market Sentiment and Analyst Recommendations

The overall market sentiment around Align Technology remains optimistic. A consensus has been reached among analysts, with a recommendation mean score of 2.06, leaning towards a “buy” position. Analysts have set a high price target of $220.00 with a mean target of $180.50. This indicates a significant potential upside compared to the current valuation, suggesting robust expectations for future growth.

Key analyst insights include:

• Buy Recommendations: Majority consensus indicates strong confidence in Align’s ability to rebound.
• Price Target Range:
• High: $220.00
• Mean: $180.50
• Low: $150.00
• Current Price vs. Price Target: Current price at $141.69 indicates room for growth and investment opportunity.

Investors should remain vigilant, as the presence of short positions (approximately 4.67% of float) indicates some market participants’ wariness about potential declines. While the bearish trend remains present, the supportive emerging developments and financial stability reported by Align Technology present both an opportunity and a risk for retail investors navigating this stock.

Conclusion

Align Technology, Inc. (ALGN) presents a compelling investment case amidst its current market dynamics. With robust financial performance, innovative product offerings, and a positive market outlook, the company remains well-positioned to capitalize on the rapid advancements in medical technology and a growing healthcare market. However, potential investors should factor in the ongoing bearish trends and market sentiment while monitoring the critical support and resistance levels that may dictate the stock’s near-term performance.

Investing in Align Technology could thus not only yield significant returns but also entail managing the associated risks within the healthcare industry landscape as it evolves.

---

This report is intended for informational purposes only and should not be construed as investment advice. Always consult with a financial advisor before making investment decisions.

Metric	Value
Market Cap	$10.2b
Total Debt	$121.3m
Total Cash	$1.0b
Shares Outstanding	71.7m
Float Shares	67.2m